Cytosorbents Corporation (CTSO)

Cytosorbents Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.2	3.28	14.13	22.14	52.14	71.42
Cash & Short-Term Investments	10.2	3.28	14.13	22.14	52.14	71.42
Cash Growth	20.63%	-76.79%	-36.19%	-57.53%	-27.00%	483.87%
Receivables	7.74	7.32	6.06	5.66	4.52	5.16
Inventory	3.71	2.73	3.38	3.46	4.77	2.67
Prepaid Expenses	1.33	3.27	1.83	2.49	2.87	3.2
Restricted Cash	-	5	-	-	-	-
Total Current Assets	22.99	21.6	25.4	33.76	64.3	82.45
Property, Plant & Equipment	19.69	20.51	22.12	23.35	18.57	3.15
Other Intangible Assets	3.74	3.75	3.91	4.39	4.7	4.22
Other Long-Term Assets	1.58	1.51	1.54	1.73	1.94	0.13
Total Assets	47.99	47.37	52.96	63.23	89.52	89.95
Accounts Payable	3.39	3.34	3.8	1.66	2.81	1.84
Accrued Expenses	4.61	4.75	4.99	6.43	8.37	7.14
Current Portion of Long-Term Debt	-	-	2.5	-	-	-
Current Portion of Leases	0.5	0.45	0.37	0.11	0.57	0.45
Current Unearned Revenue	0.36	0.42	1.38	1.52	1.95	0.73
Other Current Liabilities	0.99	0.87	0.99	-	-	-
Total Current Liabilities	9.84	9.82	14.04	9.71	13.69	10.15
Long-Term Debt	14.38	14	2.54	5	-	-
Long-Term Leases	12.19	12.44	12.9	13.14	13.25	0.58
Total Liabilities	36.4	36.26	29.48	27.86	26.94	10.73
Common Stock	0.06	0.05	0.05	0.04	0.04	0.04
Additional Paid-In Capital	319.02	310.81	306.19	287	283.19	277.53
Retained Earnings	-303.54	-304.01	-283.29	-254	-221.19	-196.63
Comprehensive Income & Other	-3.96	4.25	0.53	2.33	0.53	-1.73
Shareholders' Equity	11.59	11.11	23.48	35.37	62.58	79.22
Total Liabilities & Equity	47.99	47.37	52.96	63.23	89.52	89.95
Total Debt	27.06	26.89	18.31	18.25	13.82	1.03
Net Cash (Debt)	-16.85	-23.61	-4.18	3.89	38.32	70.39
Net Cash Growth	-	-	-	-89.84%	-45.57%	-
Net Cash Per Share	-0.29	-0.43	-0.09	0.09	0.88	1.81
Filing Date Shares Outstanding	62.76	62.5	54.29	43.66	43.51	43.26
Total Common Shares Outstanding	62.61	54.83	54.24	43.64	43.48	43.22
Working Capital	13.15	11.78	11.36	24.05	50.61	72.3
Book Value Per Share	0.19	0.20	0.43	0.81	1.44	1.83
Tangible Book Value	7.85	7.36	19.57	30.98	57.88	74.99
Tangible Book Value Per Share	0.13	0.13	0.36	0.71	1.33	1.74
Machinery	7.16	6.94	6.87	6.44	7.29	5.4
Leasehold Improvements	6.31	6.28	6.22	6.2	2.62	0.97

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q